Levosimendan affects oxidative and inflammatory pathways in the diaphragm of ventilated endotoxemic mice

Critical Care

Volumn 19, Issue 1, 2015, Pages

  Schellekens, Willem Jan M ^a   van Hees, Hieronymus W H ^a   Linkels, Marianne ^a   Dekhuijzen, P N Richard ^a   Scheffer, Gert Jan ^a   van der Hoeven, Johannes G ^a   Heunks, Leo M A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; LEVOSIMENDAN; MESSENGER RNA; NITRIC OXIDE SYNTHASE; 4-HYDROXY-2-NONENAL; ALDEHYDE; CARDIOTONIC AGENT; CHEMOKINE; HYDRAZONE DERIVATIVE; INTERLEUKIN DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BIOCHEMICAL ANALYSIS; BLOOD ANALYSIS; CONTROLLED STUDY; DIAPHRAGM; DIAPHRAGM MUSCLE; ENDOTOXEMIA; INFLAMMATION; MALE; MOUSE; NITROSATIVE STRESS; NITROSYLATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); ANIMAL; C57BL MOUSE; GENETICS; METABOLISM;

ALDEHYDES; ANIMALS; CARDIOTONIC AGENTS; CHEMOKINES; DIAPHRAGM; ENDOTOXEMIA; HYDRAZONES; INFLAMMATION; INTERLEUKINS; MICE, INBRED C57BL; MODELS, ANIMAL; NITRIC OXIDE SYNTHASE; PYRIDAZINES; RESPIRATION, ARTIFICIAL; RNA, MESSENGER;

EID: 85016650220     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-015-0798-8     Document Type: Article

References (50)

1. Levine S, Nguyen T, Taylor N, Friscia ME, Budak MT, Rothenberg P, et al. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med. 2008;358:1327-35.
2. Jaber S, Petrof BJ, Jung B, Chanques G, Berthet JP, Rabuel C, et al. Rapidly progressive diaphragmatic weakness and injury during mechanical ventilation in humans. Am J Respir Crit Care Med. 2011;183:364-71.
3. Callahan LA, Supinski GS. Sepsis-induced myopathy. Crit Care Med. 2009;37:S354-67.
4. Hooijman PE, Beishuizen A, de Waard MC, de Man FS, Vermeijden JW, Steenvoorde P, et al. Diaphragm fiber strength is reduced in critically ill patients and restored by a troponin activator. Am J Respir Crit Care Med. 2014;189:863-5.
5. Supinski GS, Ji X, Wang W, Callahan LA. The extrinsic caspase pathway modulates endotoxin-induced diaphragm contractile dysfunction. J Appl Physiol. 2007;102:1649-57.
6. Hermans G, Agten A, Testelmans D, Decramer M, Gayan-Ramirez G. Increased duration of mechanical ventilation is associated with decreased diaphragmatic force: a prospective observational study. Crit Care. 2010;14:R127.
7. Petrof B, Jaber S, Matecki S. Ventilator-induced diaphragmatic dysfunction. Curr Opin Crit Care. 2009;16:19-25.
8. Powers SK. Calpain and caspase-3 are required for sepsis-induced diaphragmatic weakness. J Appl Physiol. 2009;107:1369.
9. Supinski GS, Vanags J, Callahan LA. Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction. Am J Physiol Lung Cell Mol Physiol. 2009;296:L994-1001.
10. Ebihara S, Hussain SNA, Danialou G, Cho WK, Gottfried SB, Petrof BJ. Mechanical ventilation protects against diaphragm injury in sepsis: interaction of oxidative and mechanical stresses. Am J Respir Crit Care Med. 2002;165:221-8.
11. Betters JL, Criswell DS, Shanely RA, Van Gammeren D, Falk D, Deruisseau KC, et al. Trolox attenuates mechanical ventilation-induced diaphragmatic dysfunction and proteolysis. Am J Respir Crit Care Med. 2004;170:1179-84.
12. DeRuisseau KC, Kavazis AN, Deering MA, Falk DJ, Van Gammeren D, Yimlamai T, et al. Mechanical ventilation induces alterations of the ubiquitin-proteasome pathway in the diaphragm. J Appl Physiol. 2005;98:1314-21.
13. Levine S, Biswas C, Dierov J, Barsotti R, Shrager JB, Nguyen T, et al. Increased proteolysis, myosin depletion, and atrophic AKT-FOXO signaling in human diaphragm disuse. Am J Respir Crit Care Med. 2011;183:483-90.
14. Vary TC. Regulation of skeletal muscle protein turnover during sepsis. Curr Opin Clin Nutr Metab Care. 1998;1:217-24.
15. van Hees HWH, Schellekens WJM, Linkels M, Leenders F, Zoll J, Donders R, et al. Plasma from septic shock patients induces loss of muscle protein. Crit Care. 2011;15:R233.
16. Schellekens WJM, van Hees HWH, Vaneker M, Linkels M, Dekhuijzen PNR, Scheffer GJ, et al. Toll-like receptor 4 signaling in ventilator-induced diaphragm atrophy. Anesthesiology. 2012;117:329-38.
17. Schellekens WJM, van Hees HW, Kox M, Linkels M, Acuña GL, Dekhuijzen PNR, et al. Hypercapnia attenuates ventilator-induced diaphragm atrophy and modulates dysfunction. Crit Care. 2014;18:R28.
18. van Hees HWH, Dekhuijzen PNR, Heunks LMA. Levosimendan enhances force generation of diaphragm muscle from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;179:41-7.
19. Doorduin J, Sinderby CA, Beck J, Stegeman DF, van Hees HW, van der Hoeven JG, et al. The calcium sensitizer levosimendan improves human diaphragm function. Am J Respir Crit Care Med. 2011;185:90-5.
20. Follath F, Cleland JGF, Just H, Papp JGY, Scholz H, Peuhkurinen K, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet. 2002;360:196-202.
21. Sareila O, Korhonen R, Auvinen H, Hämäläinen M, Kankaanranta H, Nissinen E, et al. Effects of levo- and dextrosimendan on NF-κB-mediated transcription, iNOS expression and NO production in response to inflammatory stimuli. Br J Pharmacol. 2008;155:884-95.
22. Boost KA, Hoegl S, Dolfen A, Czerwonka H, Scheiermann P, Zwissler B, et al. Inhaled levosimendan reduces mortality and release of proinflammatory mediators in a rat model of experimental ventilator-induced lung injury. Crit Care Med. 2008;36:1873-9.
23. ATP channels and nitric oxide. J Cardiovasc Pharmacol. 2011;57:246-58.
24. Scheiermann P, Ahluwalia D, Hoegl S, Dolfen A, Revermann M, Zwissler B, et al. Effects of intravenous and inhaled levosimendan in severe rodent sepsis. Intensive Care Med. 2009;35:1412-9.
25. Ottenheijm CAC, Heunks LMA, Geraedts MCP, Dekhuijzen PNR. Hypoxia-induced skeletal muscle fiber dysfunction: role for reactive nitrogen species. Am J Physiol Lung Cell Mol Physiol. 2006;290:L127-35.
26. Ottenheijm CAC, Heunks LMA, Li YP, Jin B, Minnaard R, van Hees HWH, et al. Activation of the ubiquitin-proteasome pathway in the diaphragm in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;174:997-1002.
27. Vaneker M, Joosten LA, Heunks LMA, Snijdelaar DG, Halbertsma FJ, van Egmond J, et al. Low-tidal-volume mechanical ventilation induces a Toll-like receptor 4-dependent inflammatory response in healthy mice. Anesthesiology. 2008;109:465-72.
28. Supinski GS, Callahan LA. Caspase activation contributes to endotoxin-induced diaphragm weakness. J Appl Physiol. 2006;100:1770-7.
29. Hussain SN, Giaid A, El Dawiri Q, Sakkal D, Hattori R, Guo Y. Expression of nitric oxide synthases and GTP cyclohydrolase I in the ventilatory and limb muscles during endotoxemia. Am J Respir Cell Mol Biol. 1997;17:173-80.
30. Boczkowski J, Lisdero CL, Lanone S, Samb A, Carreras MC, Boveris A, et al. Endogenous peroxynitrite mediates mitochondrial dysfunction in rat diaphragm during endotoxemia. FASEB J. 1999;13:1637-46.
31. Demoule A, Divangahi M, Yahiaoui L, Danialou G, Gvozdic D, Labbe K, et al. Endotoxin triggers nuclear factor-κB-dependent up-regulation of multiple proinflammatory genes in the diaphragm. Am J Respir Crit Care Med. 2006;174:646-53.
32. Borge BAS, Kalland KH, Olsen S, Bletsa A, Berggreen E, Wiig H. Cytokines are produced locally by myocytes in rat skeletal muscle during endotoxemia. Am J Physiol Heart Circ Physiol. 2009;296:H735-44.
33. McClung JM, Kavazis AN, DeRuisseau KC, Falk DJ, Deering MA, Lee Y, et al. Caspase-3 regulation of diaphragm myonuclear domain during mechanical ventilation-induced atrophy. Am J Respir Crit Care Med. 2007;175:150-9.
34. McClung JM, Kavazis AN, Whidden MA, Deruisseau KC, Falk DJ, Criswell DS, et al. Antioxidant administration attenuates mechanical ventilation-induced rat diaphragm muscle atrophy independent of protein kinase B (PKB Akt) signalling. J Physiol. 2007;585:203-15.
35. Fareed MU, Evenson AR, Wei W, Menconi M, Poylin V, Petkova V, et al. Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression. Am J Physiol Regul Integr Comp Physiol. 2006;290:R1589-97.
36. Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2008;295:L379-99.
37. Supinski G, Stofan D, Callahan LA, Nethery D, Nosek TM, DiMarco A. Peroxynitrite induces contractile dysfunction and lipid peroxidation in the diaphragm. J Appl Physiol. 1999;87:783-91.
38. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87:315-424.
39. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996;271:C1424-37.
40. Vallance P, Leiper J. Blocking NO synthesis: how, where and why? Nat Rev Drug Discov. 2002;1:939-50.
41. Gecit I, Kavak S, Yüksel MB, Basel H, Bektas H, Gümrükçüoglu HA, et al. Effect of short-term treatment with levosimendan on oxidative stress in renal tissues of rats. Toxicol Ind Health. 2014;30:47-51.
42. van der Vliet A, Eiserich JP, Halliwell B, Cross CE. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite: a potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem. 1997;272:7617-25.
43. Yapici D, Altunkan Z, Ozeren M, Bilgin E, Balli E, Tamer L, et al. Effects of levosimendan on myocardial ischaemia-reperfusion injury. Eur J Anaesthesiol. 2008;25:8-14.
44. Katircioglu SF, Seren M, Parlar AI, Turan NN, Manavbasi Y, Aydog G, et al. Levosimendan effect on spinal cord ischemia-reperfusion injury following aortic clamping. J Card Surg. 2008;23:44-8.
45. Chew MS, Hawthorne WJ, Bendall J, Whereat S, Huang S, Ting I, et al. No beneficial effects of levosimendan in acute porcine endotoxaemia. Acta Anaesthesiol Scand. 2011;55:851-61.
46. Zager RA, Johnson AC, Lund S, Hanson SY, Abrass CK. Levosimendan protects against experimental endotoxemic acute renal failure. Am J Physiol Renal Physiol. 2006;290:F1453-62.
47. Min/+ mouse. Pflugers Arch. 2009;457:989-1001.
48. van Hees HWH, Andrade Acuña G, Linkels M, Dekhuijzen PNR, Heunks LMA. Levosimendan improves calcium sensitivity of diaphragm muscle fibres from a rat model of heart failure. Br J Pharmacol. 2011;162:566-73.
49. Remick DG, Ward PA. Evaluation of endotoxin models for the study of sepsis. Shock. 2005;24:7-11.
50. Fuhrmann JT, Schmeisser A, Schulze MR, Wunderlich C, Schoen SP, Rauwolf T, et al. Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction. Crit Care Med. 2008;36:2257-66.